Daniel A Vardy
Overview
Explore the profile of Daniel A Vardy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magen E, Masalha A, Zueva E, Vardy D
Isr Med Assoc J
. 2018 Mar;
20(3):192-193.
PMID: 29527861
No abstract available.
2.
Shalom G, Babaev M, Freud T, Tiosano S, Pam N, Horev A, et al.
J Am Acad Dermatol
. 2017 Oct;
77(6):1047-1052.e2.
PMID: 28989106
Background: Data on the health care utilization of patients with hidradenitis suppurativa (HS) in primary care settings are scarce. Objective: To investigate the health care service utilization of patients with...
3.
Shalom G, Freud T, Ben Yakov G, Khoury R, Dreiher J, Vardy D, et al.
J Invest Dermatol
. 2016 Apr;
136(8):1716-1718.
PMID: 27094593
No abstract available.
4.
Cohen A, Andrews I, Medvedovsky E, Peleg R, Vardy D
Isr Med Assoc J
. 2014 Mar;
16(2):88-90.
PMID: 24645226
Background: Localized itch of non-pruritoceptive origin is often neuropathic and may be referred to as neuropathic itch syndrome. Objectives: To describe the results of nerve conduction studies in patients with...
5.
Kahan N, Vardy D, Waitman D, Brill G
Am J Manag Care
. 2013 Oct;
19(8):e301-8.
PMID: 24125493
Background: After a new formulation of levothyroxine was distributed in Israel, side effects were reported to the Ministry of Health generating extensive media coverage. The purpose of this study was...
6.
Kahan N, Chinitz D, Blackman S, Waitman D, Vardy D
Br J Clin Pharmacol
. 2011 Jun;
72(6):997-1001.
PMID: 21689138
Aims: To evaluate whether rescinding the prior authorization (PA) requirement (managerial pre-approval) for losartan in an health maintenance organization (HMO) could reduce prescribing of the more expensive angiotensin receptor blockers...
7.
Kahan N, Waitman D, Blackman S, Vardy D
J Manag Care Pharm
. 2010 Jun;
16(5):355-9.
PMID: 20518588
Background: Policy development to manage new off-label uses of medications is an issue relevant to health policy stakeholders internationally. Retrospective drug utilization analyses may be useful to identify practice trends...
8.
Kahan N, Waitman D, Blackman S, Vardy D
Am J Manag Care
. 2009 Sep;
15(9):582-4.
PMID: 19747022
Objective: To ascertain whether revocation of a prior authorization (PA) requirement by the Leumit Health Fund of Israel resulted in inferior rates of glycosylated hemoglobin (A1C) testing among new users...
9.
Goldbart A, Dreiher J, Vardy D, Alkrinawi S, Cohen A
BMC Pulm Med
. 2009 Apr;
9:12.
PMID: 19366453
Background: Nonattendance for scheduled appointments disturbs the effective management of pediatric pulmonary clinics. We hypothesized that the reasons for non-attendance and the necessary solutions might be different in pediatric pulmonary...
10.
Kahan N, Waitman D, Vardy D
Am J Manag Care
. 2009 Mar;
15(3):173-6.
PMID: 19298098
Objective: To increase appropriate use of blood tests for folic acid and vitamin B12 ordered by primary care physicians in a managed care organization in Israel through redesign of a...